Publication | Closed Access

Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study

Drug SafetyPulmonary TuberculosisTuberculosis PreventionPediatricsDaily RifapentineTuberculosisPharmacotherapyMedicineProspective Cohort StudyDrug Resistance